DL Life Logo March 23, 2013 - - - - 117,280 AMERICANS ARE CANDIDATES ON THE UNOS TRANSPLANT WAIT LIST DL Life Logo 95,578 waiting for a kidney DL Life Logo 15,712 wait-listed for a liver DL Life Logo 1,189 waiting for a pancreasDL Life Logo 2,136 needing a Kidney-PancreasDL Life Logo 3,490 waiting for a life-saving heartDL Life Logo 1,668 waiting for a lungDL Life Logo 50 waiting for a heart-lungDL Life Logo 257 waiting for small bowelDL Life Logo One organ donor has the opportunity to save up to 8 lives DL Life Logo One tissue donor has the opportunity to save and -or enhance the lives of 50 or more individuals DL Life Logo You have the power to SAVE Lives by becoming an organ, eye and tissue donor, so what are you waiting for? To learn how to register click HEREDL Life Logo

Monday, April 16, 2012

Cheney’s Heart Transplant Highlights Issues in Heart Transplantation

Columbia Surgery



When he received a heart transplant March 24, 2012, former Vice President Dick Cheney joined about 2300 Americans who receive the lifesaving gift of a donor heart each year. After a 20-month wait on the organ waitlist, Cheney was fortunate; the shortage of donor organs remains an extreme problem, and many patients die before an organ becomes available.

Cheney’s weakened heart was supported since 2010 by a left ventricular assist device, an implantable mechanical heart pump. According to Craig Smith, MD, Chairman of the Department of Surgery at NewYork-Presbyterian/Columbia, “His transplant illustrates the increasing success of LVADs to bridge patients through extremely long waiting times.” Despite the risks associated with LVADs, their safety has been improving and they are gaining increasing use both as methods to sustain patients until a heart transplant is possible (‘bridge to transplant’), as well as to sustain people indefinitely, called ‘destination therapy.’
Read more: http://www.columbiasurgery.net/2012/04/16/cheneys-heart-transplant-highlights-issues-in-heart-transplantation/Cheney’s weakened heart was supported since 2010 by a left ventricular assist device, an implantable mechanical heart pump. According to Craig Smith, MD, Chairman of the Department of Surgery at NewYork-Presbyterian/Columbia, “His transplant illustrates the increasing success of LVADs to bridge patients through extremely long waiting times.” Despite the risks associated with LVADs, their safety has been improving and they are gaining increasing use both as methods to sustain patients until a heart transplant is possible (‘bridge to transplant’), as well as to sustain people indefinitely, called ‘destination therapy.’

No comments: